MaxCyte (MXCT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MaxCyte, Inc. announced that John Johnston, Non-Executive Director, has exercised options for 10,000 shares and subsequently sold them at prices ranging from $3.93 to $4.02 per share, which represents about 3.3% of his holdings in the company. Post transactions, Johnston retains a stake of 0.1% in MaxCyte with 120,583 shares and additional option and restricted stock units. These transactions were conducted under a pre-arranged trading plan in accordance with Rule 10b5-1.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.